Your Gut is Out of Balance, Your Genes May Be Why.

FUT2 encodes a fucosyltransferase enzyme that adds sugar molecules to the lining of your digestive tract. These sugars are essentially food for certain bacterial species, particularly the beneficial Bifidobacteria and Faecalibacterium groups. Your gut bacteria feed on these sugars, and their presence or absence shapes which species can thrive.

If you carry the non-secretor variant of FUT2, roughly 20% of people carry this, your gut lining doesn’t produce these bacterial food sources at all. Your microbiome shifts toward dysbiotic bacteria that feed on mucus instead, and Bifidobacteria cannot flourish. You also absorb less vitamin B12 from food, because the bacteria that help release B12 from food particles are depleted.

You experience bloating after eating, constipation or loose stools that alternate unpredictably, cravings for carbohydrates and sugar (because dysbiotic bacteria signal for their preferred fuel), weight gain despite not overeating, and fatigue that doesn’t improve with more sleep.

VDR, the vitamin D receptor, sits on immune cells throughout your intestinal lining. When vitamin D binds to VDR, it tells your immune system to tolerate the bacteria living in your gut and to maintain the intestinal barrier. Without VDR signaling, your immune system attacks your own bacteria, weakens the gut lining, and dysbiosis takes over.

Certain VDR variants reduce the receptor’s sensitivity to vitamin D. Studies show that people with these variants need vitamin D levels 40-60% higher than the standard recommendation to achieve the same immune tolerance. Even with adequate sun exposure and normal-range bloodwork, your immune cells may still be attacking your microbiome because your VDR is not responding strongly enough. Dysbiosis deepens, intestinal permeability increases, and weight gain accelerates.

You feel chronically inflamed in your gut, experience food reactions that seem to come and go randomly, gain weight around the abdomen, have persistent digestive bloating, and notice that your weight loss plateaus despite effort, because systemic inflammation from a leaky gut drives constant calorie restriction resistance.

MTHFR encodes an enzyme that converts folate into methylfolate, the active form your cells need to methylate DNA, proteins, and neurotransmitters, and to clear homocysteine. Methylation is essential for nutrient absorption in the gut, immune cell function in the intestinal lining, and the detoxification of inflammatory metabolites produced by dysbiotic bacteria.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 40-70%. Your cells cannot methylate fast enough to both absorb nutrients and detoxify the inflammatory byproducts of dysbiosis. Your body prioritizes detoxification, and nutrient absorption suffers. You develop functional deficiencies in folate, B12, and choline even though your bloodwork looks normal.

You feel chronically fatigued despite adequate sleep, experience brain fog that worsens after high-sugar meals, notice that your digestion is slow and incomplete, struggle with anxiety that flares when dysbiosis worsens, gain weight despite eating less, and find that your metabolism seems stuck because methylation-dependent fat metabolism is impaired.

FTO regulates appetite-signaling neurons in the hypothalamus. When this gene functions normally, eating triggers signals that travel to your brain saying stop, you’re full. But the protein FTO also suppresses the production of POMC neurons, the brain cells that create satiety. A delicate balance keeps you from overeating.

Carrying the A allele of the FTO rs9939609 variant, present in roughly 45% of people with European ancestry, shifts this balance. Your POMC neurons are suppressed, satiety signaling is weakened, and you feel hungry sooner after eating and eat more before feeling full. This makes dysbiosis-driven weight gain far more severe, because dysbiotic bacteria amplify these hunger signals by producing metabolites that cross the blood-brain barrier and further suppress satiety neurotransmitters.

You feel genuinely hungry an hour after eating a full meal, crave high-calorie foods intensely, struggle to feel satisfied even when eating large portions, experience emotional eating as an attempt to override the hunger feeling, and gain weight steadily even when you’re aware of calorie intake because your appetite set point is broken.

PPARG encodes a nuclear receptor that controls how your fat cells develop, how efficiently they store energy, and how responsive they are to insulin. When PPARG functions optimally, excess calories are stored in a way that keeps your metabolism flexible. You can tap stored fat when you need energy.

If you carry the Pro12 allele of the PPARG Pro12Ala variant, present in roughly 25% of people, your fat cells are more efficient at storage. Your body preferentially stores excess calories as body fat rather than burning them, and your fat cells respond less effectively to the signals that tell them to release stored energy. This effect amplifies dramatically when dysbiosis is present, because dysbiotic bacteria produce metabolites that enhance insulin signaling to fat cells while suppressing it in muscle.

You gain weight preferentially around the abdomen, find that dietary fat makes you heavier than equivalent carbohydrate calories, experience difficulty losing weight through low-fat diets, notice that your body composition worsens even when your scale doesn’t budge much (gaining fat while losing muscle), and feel that your metabolism is fundamentally different from other people’s because it genuinely is.

TCF7L2 is a transcription factor that controls insulin secretion from pancreatic beta cells. When blood sugar rises, TCF7L2 tells your pancreas how much insulin to release and how quickly. It also regulates GLP-1, a hormone that slows digestion and increases satiety. Dysbiosis directly impairs GLP-1 production because dysbiotic bacteria cannot produce the short-chain fatty acids that trigger GLP-1 release.

Carrying the T allele of the TCF7L2 rs7903146 variant, present in roughly 30% of people, impairs both insulin secretion and GLP-1 signaling. Your pancreas either overshoots and releases too much insulin, or undershoots and leaves blood sugar elevated, and your gut cannot produce adequate GLP-1 to control appetite and digestion. When dysbiosis is present, the effect is compounded because dysbiotic bacteria cannot help regulate blood sugar anymore.

You experience energy crashes 2-3 hours after eating carbohydrates, crave sugar intensely when blood sugar dips, gain weight even when eating moderate carbohydrates because high insulin drives fat storage, feel bloated after meals and experience digestive slowness because GLP-1 signaling is impaired, and notice that your weight loss resistance intensifies when you eat more carbohydrates because your metabolism is literally designed to store carbohydrate calories as fat.